Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 16–30 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6381 ALDOA Gene Glycogen Storage Disease Type 12 (GSD XII) Genetic Test This genetic test identifies pathogenic variants in the ALDOA gene associated with Glycogen Storage Disease Type 12 (GSD XII).	Whole Blood (EDTA), Extracted DNA, or FTA Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALDOA gene", "Coding region and splice junctions of the ALDOA gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session", "No fasting or medication changes unless directed by physician"] Indications ["Clinical suspicion of GSD XII", "Unexplained haemolysis with myopathy", "Positive family history of GSD XII"] Measurement technique Confirm with laboratory Codes LOINC: 82847-5 ICD-10: E74.09 Clinical summary This genetic test identifies pathogenic variants in the ALDOA gene associated with Glycogen Storage Disease Type 12 (GSD XII).
TEST-4956 ALOX12B Gene Sequencing for Autosomal Recessive Congenital Ichthyosis Type 2 (Genetic Test) This genetic test detects pathogenic variants in the ALOX12B gene associated with autosomal recessive congenital ichthyosis type 2 (ARCI2).	Peripheral Whole Blood (EDTA), FTA Card Spot, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ALOX12B gene"] Parameters [] Preparation [] Indications ["Confirmation of ARCI2 diagnosis", "Genetic counselling for families", "Carrier status assessment for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94471-6 ICD-10: Q80.2 Clinical summary This genetic test detects pathogenic variants in the ALOX12B gene associated with autosomal recessive congenital ichthyosis type 2 (ARCI2).
TEST-2826 ALX3 Gene Frontonasal Dysplasia Type 1 Genetic Test This genetic test evaluates the ALX3 gene for pathogenic variants associated with Type 1 frontonasal dysplasia.	Whole blood (EDTA), extracted DNA, or FTA card blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALX3 gene pathogenic variants", "Copy number variations (CNVs) in ALX3"] Parameters [] Preparation [] Indications ["Suspected frontonasal dysplasia", "Family history of frontonasal dysplasia", "Recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q75.8 Clinical summary This genetic test evaluates the ALX3 gene for pathogenic variants associated with Type 1 frontonasal dysplasia.
TEST-3836 AMT Gene Glycine Encephalopathy Genetic Test This test evaluates the AMT gene for pathogenic variants associated with glycine encephalopathy (nonketotic hyperglycinemia). It utilizes Next-Generation Sequencing (NGS) for compr...	Peripheral Whole Blood, Blood Spot on FTA Card, or Extracted DNA	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the AMT gene", "Coding region and flanking exon-intron boundaries of the AMT gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab if patient is on anticoagulant therapy"] Indications ["Suspected diagnosis of glycine encephalopathy (nonketotic hyperglycinemia)", "Family history of glycine encephalopathy", "Carrier screening for at-risk individuals", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94222-5 ICD-10: E72.51 Clinical summary This test evaluates the AMT gene for pathogenic variants associated with glycine encephalopathy (nonketotic hyperglycinemia). It utilizes Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-3877 ANKS3 Gene Autism Spectrum Disorder Genetic Test This test evaluates the ANKS3 gene for variants associated with Autism Spectrum Disorder (ASD).	Whole Blood (Peripheral Venipuncture)	3–4 Weeks (21–28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single nucleotide variants in ANKS3 gene", "Small insertions or deletions (indels) in ANKS3 gene", "Copy Number Variations (CNV) in ANKS3 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy"] Indications ["Clinical suspicion of Autism Spectrum Disorder (ASD)", "Familial risk stratification for ASD", "Personalized intervention planning for ASD"] Measurement technique Confirm with laboratory Codes LOINC: 91854-2 ICD-10: F84.0 Clinical summary This test evaluates the ANKS3 gene for variants associated with Autism Spectrum Disorder (ASD).
TEST-6104 APOA2 Gene Apolipoprotein A‑II Deficiency Genetic Test This genetic test identifies pathogenic variants in the APOA2 gene associated with Apolipoprotein A‑II deficiency.	Peripheral whole blood (or FTA card)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in APOA2 gene", "Coding exons", "Splice sites", "Copy number variations (CNVs)"] Parameters [] Preparation ["Genetic counselling session mandatory before sample collection", "Draw pedigree chart of affected family members"] Indications ["Diagnosis of Apolipoprotein A‑II deficiency", "Assessment of inherited lipid disorder risk"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E78.8 Clinical summary This genetic test identifies pathogenic variants in the APOA2 gene associated with Apolipoprotein A‑II deficiency.
TEST-5288 ARSE Gene Chondrodysplasia Punctata, X-Linked Recessive Genetic Test This genetic test sequences the ARSE gene to identify pathogenic variants associated with X-linked recessive chondrodysplasia punctata (CDPX1).	Peripheral Whole Blood or Buccal Swab	21 – 28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ARSE gene sequence", "Pathogenic variants in ARSE gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected X-linked recessive chondrodysplasia punctata (CDPX1)", "Family history of CDPX1", "Need to differentiate from other peroxisomal or vitamin K-dependent disorders"] Measurement technique Confirm with laboratory Codes LOINC: 94231-7 ICD-10: Q77.3 Clinical summary This genetic test sequences the ARSE gene to identify pathogenic variants associated with X-linked recessive chondrodysplasia punctata (CDPX1).
TEST-3001 ASCL1 Gene Central Hypoventilation Syndrome, Congenital Test This diagnostic test evaluates the ASCL1 gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS). It identifies disease-causing mutations li...	Whole Blood (EDTA), Extracted DNA, FTA Card (One Drop)	3 to 4 Weeks (Expedited Processing Available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ASCL1 gene", "Full coding exons and flanking intronic regions of ASCL1"] Parameters [{"name": "Analytical Sensitivity", "reference_range": "99.9%"}, {"name": "Analytical Specificity", "reference_range": "99.9%"}, {"name": "Mean Read Depth", "reference_range": "100x"}] Preparation ["No specific fasting required", "Inform laboratory of any medications that may compromise DNA integrity"] Indications ["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Neonates and paediatric patients with abnormal respiratory control", "Family planning decisions related to CCHS risk"] Measurement technique Confirm with laboratory Codes LOINC: 92824-5 ICD-10: G47.35 Clinical summary This diagnostic test evaluates the ASCL1 gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS). It identifies disease-causing mutations linked to Ondine's Curse.
TEST-3918 ATP10A Gene Sequencing (NGS) Test This test evaluates the ATP10A gene for variants associated with neurodevelopmental disorders.	Peripheral Whole Blood, Saliva	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP10A gene sequence", "Single-nucleotide variants (SNVs)", "Small insertions or deletions (indels)"] Parameters [] Preparation ["No specific fasting required.", "Inform phlebotomist of any medications."] Indications ["Suspected genetic cause of neurodevelopmental delay", "Diagnosis of ASD", "Diagnosis of intellectual disability", "Diagnosis of Angelman syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 94835-8 ICD-10: Z13.71, F84.0, Q93.5 Clinical summary This test evaluates the ATP10A gene for variants associated with neurodevelopmental disorders.
TEST-5274 ATP6V0A2 Gene Sequencing for Autosomal Recessive Cutis Laxa Type 2A Test This test identifies pathogenic variants in the ATP6V0A2 gene, confirming a diagnosis of autosomal recessive cutis laxa type 2A.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATP6V0A2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory"] Indications ["Suspected autosomal recessive cutis laxa type 2A", "Family history of cutis laxa type 2A", "Carrier testing for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 94805-5 ICD-10: Q82.8 Clinical summary This test identifies pathogenic variants in the ATP6V0A2 gene, confirming a diagnosis of autosomal recessive cutis laxa type 2A.
TEST-3333 ATRX Gene Sequencing (NGS) for Alpha‑Thalassemia/Mental Retardation Syndrome Test This test identifies pathogenic variants in the ATRX gene associated with X-linked alpha-thalassemia/mental retardation syndrome.	Whole blood (3–5 mL in EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ATRX gene", "Copy number changes in the ATRX gene"] Parameters [] Preparation ["No fasting required", "Hydrate well", "Provide Emirates ID for home collection"] Indications ["Suspected ATR-X syndrome based on clinical presentation", "Family history of ATR-X syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 84410-0 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the ATRX gene associated with X-linked alpha-thalassemia/mental retardation syndrome.
TEST-4557 B3GALT6 Gene Analysis (Spondyloepimetaphyseal Dysplasia with Joint Laxity Type 1) Test This test identifies pathogenic variants in the B3GALT6 gene, confirming a diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1).	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the B3GALT6 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1)", "Family history of SEMD-JL1"] Measurement technique Confirm with laboratory Codes LOINC: 95240-3 ICD-10: Q77.8 Clinical summary This test identifies pathogenic variants in the B3GALT6 gene, confirming a diagnosis of spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1).
TEST-3951 BBS2 Gene Bardet‑Biedl Syndrome Type 2 Genetic Test This test evaluates the BBS2 gene for pathogenic variants associated with Bardet-Biedl syndrome type 2.	Whole Blood, Extracted DNA, FTA Card (one drop)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the BBS2 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNVs)"] Parameters [] Preparation ["Complete a detailed clinical history form", "Mandatory pre-test genetic counselling", "No dietary restrictions", "Continue usual medications unless advised otherwise", "Avoid anticoagulants if whole blood is required (consult doctor)", "An FTA card may be substituted for whole blood"] Indications ["Individuals with clinical features suggestive of Bardet-Biedl syndrome type 2", "Family members of affected patients seeking carrier or presymptomatic diagnosis after genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.8 Clinical summary This test evaluates the BBS2 gene for pathogenic variants associated with Bardet-Biedl syndrome type 2.
TEST-2254 BHLHA9 Gene Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction Genetic Test This test evaluates the BHLHA9 gene for mutations associated with mesoaxial synostotic syndactyly with phalangeal reduction.	Whole Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BHLHA9 gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute illness"] Indications ["Suspected mesoaxial synostotic syndactyly with phalangeal reduction", "Genetic confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 94228-7 ICD-10: Q87.2 Clinical summary This test evaluates the BHLHA9 gene for mutations associated with mesoaxial synostotic syndactyly with phalangeal reduction.
TEST-3023 BMPR1B Gene Brachydactyly Type A2 Genetic Test This test identifies pathogenic variants in the BMPR1B gene associated with Brachydactyly Type A2.	Peripheral Whole Blood or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BMPR1B gene coding region", "Splice sites"] Parameters [] Preparation [] Indications ["Suspected Brachydactyly Type A2", "Family history of autosomal dominant skeletal dysplasia", "Genetic counseling", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21635-7 ICD-10: Q73.8 Clinical summary This test identifies pathogenic variants in the BMPR1B gene associated with Brachydactyly Type A2.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.